RGC (regencellbioscience.com) Company Net Income

RGC (regencellbioscience.com) - company brandmark

The current profit of Regencell Bioscience (RGC), based on the operation of ideal laboratories with low utilization, has stalled at -0.01. Regencell Bioscience is developing an image as a neuromedicine innovator, focusing on the safety of pediatric health. However, its status as a biotech in the testing stage guarantees a lack of revenue and regular losses, rendering cash flows unpredictable and necessitating constant external financing.

RGC Regencell Bioscience Holdings Limited: Net Profit in the range 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Regencell Bioscience Holdings Limited (RGC)

- stock price and consensus target price:
Price Performance Chart Regencell Corp|RGC - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Regencell Corp|RGC - Enterprise Value
- balance sheet equity data:
Book Value of One Share Regencell Bioscience|RGC - Book Capitalization|Market-to-Book Ratio regencellbioscience.com|RGC - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio Regencell Bioscience|RGC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Regencell Bioscience Ltd|RGC - Company Aggregate Debts|Debts to Book Value Regencell Corp|RGC - Company Long-Term Debt|Company Short-Term Debt Regencell Bioscience|Quick Liquidity regencellbioscience.com
- business earnings and investment ratios data:
RGC - Net Income
Fundamental valuation:RGC Regencell Corp
Brand item of Regencell

This indicator provides continuous monitoring of net income, where the curve's dynamics allow for the differentiation of stable operational phases from critical structural failures within the business. An analysis of Regencell Bioscience (RGC) distributable profit confirms a lack of commercial revenue due to the clinical trial stage, turning this chart into a reflection of pure capital burn until the drugs are brought to market.

Main competitors

Biogen Idec - Final Profit|NBIX (Neurocrine Biosciences) - Net Profit|Company Net Income axsome.com AXSM|Net Profit ACAD|Xenon Pharmaceuticals Inc. (XENE) - Annual Net Income|Net Profit VKTX (Viking Pharma)|Supernus Corp (SUPN) - Company Net Income|CPRX - Company Net Income|DNLI (denalitherapeutics.com) - Company Profit|HRMY: Net Profit|Net Income Biohaven Ltd|AMLX (Amylyx) - Net Profit|Company Net Income Trevi Corp TRVI|Company Net Income Praxis Precision Medicines (PRAX)|Company Net Income AVXL (anavex.com)|Company Net Income CeriBell CBLL|Prothena Corp - Company Net Income|ALEC: Net Income|Final Profit ANNX (Annexon Biosciences Inc.)|OMER: Net Profit|NGNE (neurogene.com) - Company Net Income|ACIU (AC Immune SA) - Net Profit|Voyager Therapeutics Inc (VYGR) - Net Financial Result|Company Net Income Neumora Therapeutics Inc (NMRA)|SCLX - Company Net Income|Company Net Income Tevogen Bio Holdings TVGN|Net Financial Result Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Net Profit|Inhibikase Therapeutics Inc (IKT) - Net Income|SAVA: Net Profit|ASRT - Net Financial Result|COYA (Coya Therapeutics Inc) - Net Profit|Company Net Income VistaGen Therapeutics Inc VTGN|Company Net Income Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals Inc. - Company Profit|Net Profit CRVO (CervoMed Inc)|ATHE - Net Income|Clene Nanomedicine - Net Profit|Company Net Income PepGen Inc.|Jupiter Neurosciences Inc (JUNS) - Company Net Income|Relmada Therapeutics Inc - Final Profit|ANVS (Annovis Bio Corp) - Net Profit|GRCE - Annual Net Income|Net Profit AIFF|Net Income anewmeds.com KLTO|Company Net Income NeuroSense Therapeutics Ltd. NRSN|RVPH: Company Profit|MetaVia, Inc. - Net Profit|Company Net Income NeurAxis Inc|HSDT (heliusmedical.com) - Net Income|Passage Bio (PASG) - Net Profit|Company Net Income Neuphoria Therapeutics, Inc.|NERV: Final Profit|Company Net Income Athira (ATHA)|ADXN - Company Net Income|Company Net Income Alzamend Neuro ALZN|Final Profit CYCN|Protagenic - Net Profit|Company Net Income Pasithea Therapeutics|CRGT: Net Profit|Annual Net Income Avenue Therapeutics Inc ATXI|BCLI (Brainstorm Cell) - Net Profit|Company Net Income caratherapeutics.com CARA|Company Net Income Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Company Profit|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Net Income|Marinus Pharmaceuticals - Net Profit|Company Net Income nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|SAGE (Sage Therapeutics Inc.) - Company Net Income|Company Net Income Neurotrope|Company Net Income TRVN|Net Income VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Final Profit|Net Profit CERE (Cerevel Therapeutics, Inc.)